Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Broad Microbial Contamination Detection on one platform with results within 8 hours

Product Description

The Abbott PLEX-ID system is the only high-throughput technology that offers rapid, broad identification of known or unknown emerging organisms direct from sample, without the need for culture, enrichment or staining.

The PLEX-ID system provides the ability to screen for thousands of  adventitious agents, such as bacteria, fungi or viruses, in a single analysis with access to results within 8 hours from preparation to identification.  The PLEX-ID is commonly used during the Biopharmaceutical manufacturing process to test for Cell banking, thru to in-process testing and environmental monitoring.

The PLEX-ID technology uses broad PCR coupled with Mass Spectrometer detection to detect and determine the base composition of amplified primer pairs (amplicons) that are used to interrogate conserved regions that flank variable regions of highly conserved genes. The base composition determined for each amplicons is then searched against a database to determine the organisms present. This multilocus approach provides the ability to distinguish between closely related species as well as identify single nucleotide polymorphisms or mutations.

This Technology is not approved for use in diagnostic procedures.

Product Broad Microbial Contamination Detection on one platform with results within 8 hours
Company Abbott Laboratories – Ibis Biosciences Business Unit
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Abbott Laboratories – Ibis Biosciences Business Unit
2251 Faraday avenue, Suite 150 Carlsbad Ca 92008 USA

Tel: Sandrine.miller@abbott.com

Email: Sandrine.miller@abbott.com



Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!